Dual versus triple antithrombotic therapy, does trial design make the difference?
Session:
Dual versus Triple Antithrombotic Therapy for Patients with Atrial Fibrillation Undergoing Stenting
Topic:
Pharmacotherapy
Speaker:
Professor R. Storey (Sheffield, GB)
Event:
ESC Congress 2020
Congress Presentation
About the speaker
Professor Robert Storey
University of Sheffield, Sheffield (United Kingdom of Great Britain & Northern Ireland)
23
presentations
1
follower
3 more presentations in this session
Access the full session
Dual versus Triple Antithrombotic Therapy for Patients with Atrial Fibrillation Undergoing Stenting
Speakers:
Professor R. Storey, Professor D. Angiolillo, Professor K. Huber, Professor R. De Caterina
About the event
ESC 365 is supported by
